Impacto presupuestario de la utilización de hormona de crecimiento de la edad pediátrica a la adulta

Objective: To estimate the budget impact of somatrophin (Genotonorm ® ) use in growth hormone deficiency (GHD) patients during the transition between childhood and adulthood. Method: A budget impact model was designed under the Spanish National Health System with a 5-year time horizon. Calculations of susceptible patients were based on disease prevalence